A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center retrospective observational study
Background: interleukin (IL)-1 inhibitors have been suggested as possible therapeutic options in a large number of old and new clinical entities characterized by an IL-1 driven pathogenesis. Objectives: to perform a nationwide snapshot of the on-label and off-label use of anakinra (ANA) and canakinu...
Saved in:
Similar Items
-
The European Rheumatologist's curriculum
by: G. Valentini
Published: (2011) -
Amyloidoses as seen by the Rheumatologist
by: J.Ch Gerster
Published: (2001) -
The COVID-19 war and the battles of rheumatologists
by: Alberto Migliore, et al.
Published: (2020) -
Septic arthritis: what is the role for the rheumatologist?
by: V. Carraro, et al.
Published: (2011) -
Metformin: A Potential Therapeutic Tool for Rheumatologists
by: Teresa Salvatore, et al.
Published: (2020)